Eczema Study Links Poor Sleep With Memory and Attention Problems

Eczema may affect more than the skin: in a study of 78 working adults in Malaysia, more severe atopic dermatitis tracked with poorer sleep and greater memory difficulties. The findings suggest that nighttime symptoms can carry into the next day as problems with attention and recall. That connection matters because eczema is often discussed in terms of what’s visible on the skin, while the effects of a disrupted night may be less obvious at a daytime appointment. The study doesn’t show that eczema directly caused the memory difficulties, but it does point to sleep as part of the condition’s broader daily burden.

Sleep disruption rose with severity

Researchers assessed participants’ sleep with the Pittsburgh Sleep Quality Index and everyday memory with the Everyday Memory Questionnaire-Revised. Across the group, 77% reported poor sleep quality and 64% showed memory dysfunction. Both measures worsened as eczema became more severe. These results describe a pattern within this group, rather than a measure of how common the same difficulties are among all people with eczema. Still, the two assessments give a view of both reported sleep problems and the everyday memory complaints participants experienced.

Participants with severe eczema took an average of 63 minutes to fall asleep, compared with 32 minutes among those with mild eczema. Though both groups spent about 7.3 hours in bed, people with severe eczema averaged only 4.5 hours of sleep; those with mild eczema got 6.7 hours. The gap between time in bed and time asleep points to a problem that a simple bedtime schedule can miss: being in bed for longer doesn’t necessarily mean getting enough uninterrupted rest. This is more significant than it looks, because the researchers found the differences alongside a broader decline in sleep measures as disease severity increased.

Symptoms frequently interrupted the night. Itch woke 53% of participants at least three times a week, while feeling too hot affected 37% and skin pain affected 32%. Sleep duration, efficiency, time to fall asleep and daytime functioning all declined as disease severity increased. Each symptom offers a plausible reason for waking, but the study doesn’t establish which one mattered most for any individual participant. And this is the part most people overlook: repeated disruption can leave someone feeling the effects during the day even when they’ve set aside what seems like enough time to sleep.

Memory scores followed a similar pattern. Attention deficits were reported in 67% of participants with severe eczema, versus 23% of those with mild cases. That difference is a reported association in this group, not proof that more severe skin symptoms alone account for poorer attention. Even so, it gives clinicians and patients a concrete reason to ask about concentration and recall, rather than assuming that eczema’s effects stop when a flare isn’t being discussed.

Sleep quality may help explain the cognitive effects

Poor sleep quality and daytime dysfunction independently predicted memory impairment in the analysis, even after researchers accounted for age, eczema severity and medication use. Greater sleep disturbance also correlated with more trouble retrieving information and keeping track of attention. In other words, the reported memory problems weren’t tied only to the severity of the skin condition in the analysis; sleep measures also carried information. That’s suggestive, though statistical prediction within one study doesn’t establish a cause-and-effect pathway.

That distinction matters: time in bed didn’t tell the full story. Participants with severe eczema spent about as long in bed as those with mild disease but slept substantially less. The results point to fragmented sleep as a possible contributor to next-day cognitive difficulties, though the study can’t establish that poor sleep directly causes memory problems. Similar patterns can arise when symptoms, sleep and daytime functioning affect one another, so the direction of the relationship remains an open question here. The study’s measures capture an association, not a sequence showing what happened first.

Caffeine intake and antihistamine use were also associated with worse outcomes in this group. The study doesn’t explain why, so those findings should be read as associations rather than evidence that either factor caused the difficulties. They also don’t support a simple recommendation to stop caffeine or change medication. If you’re working in this space, that distinction is worth keeping in view: an association can flag a topic for discussion, but it can’t tell a patient which choice will improve sleep or memory.

What the findings suggest for care

Nighttime itch, pain and heat were common reasons for waking. A consistent evening skin care routine, including prescribed treatments and moisturizer, may help some people manage symptoms overnight. Keeping the bedroom cool may also address heat-related waking. These are practical measures that match the symptoms participants reported, but the study didn’t test whether any particular routine improved sleep. People considering changes to medication or caffeine use can discuss them with a clinician. Small steps, guided by the symptoms that actually interrupt sleep.

The practical message is to include sleep and daytime concentration in conversations about eczema care. Working with a dermatologist or physician on a manageable plan for flare prevention and symptom relief may help address the condition’s effects across the day. Patients can describe how often itch, pain or heat wakes them, as well as whether they’re struggling to focus or remember everyday tasks. What this means for you is that a discussion of skin symptoms can reasonably include questions about the night and the following day, even when the appointment is focused on eczema treatment.

The study involved a relatively small group of employed adults, so larger research is needed to see whether the same patterns hold more broadly. Its participants may not reflect people with eczema in other circumstances, and the findings can’t establish that the relationship would look the same across different groups. The measures also show reported difficulties rather than proving a specific biological explanation for them. Those limits don’t make the results irrelevant; they define how far the conclusions can travel.

Why the connection deserves attention

For care teams, the study makes a case for treating sleep as useful context when assessing the burden of atopic dermatitis. A patient may report worsening concentration without connecting it to repeated waking, or may mention itchy nights without describing their daytime effects. Asking about both could give clinicians a fuller account of how symptoms are affecting daily life. That said, the findings don’t show that improving sleep will necessarily resolve memory complaints, and any care plan still needs to respond to the individual’s symptoms and circumstances.

The larger implication is modest but useful: the impact of eczema may be easier to understand when skin symptoms, sleep and daytime functioning are considered together. The study can’t settle whether sleep disruption drives cognitive difficulties, whether more severe symptoms drive both, or whether several factors are involved. It does show that these problems appeared together in the adults assessed. A clearer picture of that relationship will depend on further research, while clinicians can already make room for sleep and concentration in ordinary conversations about eczema.